Drug Target Review

SEPTEMBER 24, 2024

By aligning all departments and research teams to a common set of data management standards, organisations can prevent the fragmentation and inconsistency that often arise when different teams operate in silos. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

Government 59

Government Science Research Drugs 59

Drug Target Review

JUNE 24, 2024

He is also CEO and co-Founder of Incubate Bio – a techbio providing a service to life sciences companies who are looking to accelerate their research and lower their wet lab costs through in silico modelling. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

Science 69

Science Engineering Research Drugs 69

Drug Target Review

AUGUST 14, 2024

He is also a co-founder of Incubate Bio – a techbio providing a service to life sciences companies who are looking to accelerate their research and lower their wet lab costs through in silico modelling. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

Engineering 59

Engineering Science Drugs Research 59

Drug Target Review

MAY 24, 2024

He is also CEO and co-Founder of Incubate Bio – a techbio providing a service to life sciences companies who are looking to accelerate their research and lower their wet lab costs through in silico modelling. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

RNA 59

RNA DNA Bioinformatics Science 59

The Pharma Data

NOVEMBER 11, 2020

Dr. McChesney is the founder and chief executive officer of Cloaked Therapeutics and Arbor Therapeutics, through which he has drawn on more than five decades of research in natural products chemistry to identify and develop novel cancer treatments. a consulting and research firm where he acted as the principal until 2017.

Organic Chemistry 52

Organic Chemistry Science Pharmaceuticals Pharmacy 52

The Pharma Data

MARCH 8, 2021

Ridgeback markets EbangaTM for the treatment of Ebola and has a late-stage development pipeline which includes molnupiravir for the treatment of COVID-19. About Molnupiravir. About Ridgeback Biotherapeutics. Headquartered in Miami, Florida, Ridgeback Biotherapeutics LP is a biotechnology company focused on emerging infectious diseases.

Trials 69

Trials Virus RNA Research Laboratories 69

Drug Target Review

SEPTEMBER 13, 2024

Data documentation Researchers should maintain detailed metadata for each dataset, including information about the origin, collection method, and any preprocessing steps. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

Science 59

Science Research Marketing Drugs 59

The Pharma Data

JANUARY 25, 2021

BioArctic AB (publ) is a Swedish research-based biopharma company focusing on disease-modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. The company was founded in 2003 based on innovative research from Uppsala University , Sweden.

Pharmaceutical Companies 40

Pharmaceutical Companies Disease Treatment Pharmaceuticals 40

Drug Target Review

FEBRUARY 14, 2025

From hypothesis generation to data cleaning and interpretation, the appropriate use of tools can significantly improve the efficiency and accuracy of the research process. Data cleaning and descriptive analytics tools Excel remains one of the most commonly used tools for data cleaning and descriptive analytics in many research settings.

Drugs 52

Drugs Research Immune Response Science 52

The Pharma Data

JANUARY 26, 2021

The granted patent underlines BioArctic’s commitment in the brain diseases field in general and in Alzheimer’s disease research specifically. The company was founded in 2003 based on innovative research from Uppsala University , Sweden. For more information about BioArctic, please visit www.bioarctic.com.

Disease 40

Disease Pharmaceutical Companies Treatment Licensing 40

Drug Target Review

OCTOBER 24, 2024

He is also a co-founder of Incubate Bio – a techbio providing a service to life sciences companies who are looking to accelerate their research and lower their wet lab costs through in silico modelling. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

Cell Based Assays 52

Cell Based Assays Science Disease Doctors 52

Drug Target Review

OCTOBER 14, 2024

He is also a co-founder of Incubate Bio, a techbio providing a service to life sciences companies who are looking to accelerate their research and lower their wet lab costs through in silico modelling. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

Science 52

Science Pharmaceutical Companies Drug Development Pharmaceuticals 52

The Pharma Data

MARCH 13, 2021

Fei-Fei Li (44), a leading expert in artificial intelligence and Professor in the Computer Science Department at Stanford University in California, and Alberto Weisser (65), a renowned agricultural expert with decades of capital market experience in the United States. Li and Weisser are intended to succeed Johanna W. “Fei-Fei

International 52

International Engineering Science Marketing 52

The Pharma Data

OCTOBER 1, 2021

Currently, the quality dose for all marketed GBCAs, including gadobutrol and gadoterate, is 0.1 Dr. Olaf Weber, Head of Radiology Research and Development at Bayer. additionally , Bayer is strongly committed to research and development and leverages AI , thus further driving innovation in medical imaging. mmol/kg weight. “At

Clinical Trials 52

Clinical Trials Disease Production Hospitals 52

The Premier Consulting Blog

JANUARY 17, 2023

The Pediatric Research Equity Act (PREA) was signed into law in 2003 to increase pediatric use information in product labeling and close knowledge gaps regarding the safety, efficacy, and appropriate dosing of drugs to treat children.

Production 52

Production Clinical Trials FDA Disease 52

BMG Labtech

OCTOBER 4, 2023

In this blog, we examine how quality control of nucleic acids on microplates before sequencing can facilitate next-generation sequencing and look at some of the emerging next-generation sequencing solutions available to researchers. How can you use microplate readers for NGS research?

DNA 52

DNA RNA Bioinformatics Research 52

The Pharma Data

DECEMBER 15, 2020

Klisyri will be manufactured by Athenex, highlighting the vertically integrated capabilities of the company ranging from a preclinical lead to a developed product for market launch. Mr. Peter Guenter, CEO of Almirall, stated, “We are delighted to partner with Athenex to market Klisyri in the U.S. Founded in 2003, Athenex, Inc.

FDA Approval 52

FDA Approval Treatment FDA Therapies 52

Perficient: Drug Development

JANUARY 25, 2024

This is a disappointing reversal for payers, as the 2010 results showed a nine-point gain compared to the 2003 figure. Gallup’s researchers noted several factors that may account for the healthcare industry’s nearly universal decreases in customer trust and satisfaction. But there are opportunities for advancing your position.

Nurses 52

Nurses Health Insurance Companies Pharmaceutical Companies Hospitals 52

The Pharma Data

NOVEMBER 9, 2020

The Company is also engaged in a broad, comprehensive clinical research collaboration with The University of Texas MD Anderson Cancer Center to further expand the NBTXR3 development program. Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP).

Immune Response 40

Immune Response Therapies Clinical Trials Treatment 40

Agency IQ

SEPTEMBER 15, 2023

Until recently, the FDA relied on a monograph process through which firms could bring OTC drugs to market without FDA approval so long as it adhered to pre-set terms under the monograph. Their research showed that consumers prefer oral formulations over intranasal at a rate of 3 to 1. billion, compared with retail sales of $0.5

Science 40

Science FDA Clinical Trials Clinical Pharmacology 40

Agency IQ

FEBRUARY 21, 2024

In 2003, the CTD became the mandatory format for new drug applications in the EU and Japan, and the “strongly recommended format” for submission of applications to the FDA. FDA has leaned heavily into the use of HL7 across all medical product types to reduce the barriers for leveraging clinical information for research.

Science 40

Science Regulations International FDA 40

PLOS: DNA Science

JUNE 13, 2024

Through graphics and five main points, Chan countered the wet market scenario of the pandemic’s beginnings. The virus SARS-CoV-2 emerged in Wuhan, home of a premiere research institute that focuses on viruses. The evidence supporting viral origin at the Huanan seafood market was never compelling – it just seemed possible.

Virus 52

Virus RNA DNA Science 52

The Pharma Data

OCTOBER 19, 2020

The Company is also engaged in a broad, comprehensive clinical research collaboration with The University of Texas MD Anderson Cancer Center to further expand the NBTXR3 development program. Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP).

Clinical Trials 40

Clinical Trials Immune Response Trials Therapies 40

Codon

SEPTEMBER 8, 2024

deaths per 100,000 women in 2003 to close to 1 per 100,000 in 2020. Scott Winship , a sociologist at the American Enterprise Institute—and creator of the third chart—argues that these differences stem from researchers measuring worker pay and worker productivity in different, and sometimes incompatible, ways. residents.

Production 114

Production Engineering Science Research 114

FDA Law Blog: Biosimilars

AUGUST 29, 2024

3582 went nowhere; and many additional unsuccessful attempts to get a similar bill passed followed over the years. But like cockroaches, some pieces of legislation are resilient and never seem to die. And like its predecessor bills, S. 142 includes narrow exceptions: (B) Exception.

Biosimilars 59

Biosimilars Licensing Licensing Production 59

Codon

FEBRUARY 27, 2024

It was March 2003, and an unfortunate 33-year-old, known only as patient YY, was suffering from intense diarrhea. A company called LuminOre will soon bring copper-coated air ducts to the market. Last year, researchers at the University of Birmingham announced the invention of a sprayable coating derived from cellulose.

Virus 70

Virus Hospitals Production Regulations 70

The Pharma Data

MARCH 17, 2021

Nally, chief marketing officer, Human Health, will leave the company at the end of March, and Frank Clyburn, chief commercial officer, Human Health, will become president, Human Health and lead all Human Health commercial and marketing for the company. Nally is leaving Merck for a leadership opportunity with another company. “As

Research Laboratories 52

Research Laboratories Laboratories Marketing Vaccine 52

The Pharma Data

MAY 13, 2021

I began to research what I was missing from my exercise toolbox when it came to getting the fastest and best results for my clients. Fitness professionals work long hours and it is difficult to find the time or energy to sit down and read a textbook on exercise physiology or to look up the latest research articles. s a topic Iâ??ve

Production 52

Production Treatment Vaccine Therapies 52

Agency IQ

APRIL 8, 2024

Since these issues could occur during the investigational phase of clinical development as well as in the post-marketing setting—and product status could very well differ by country/region—ICH members determined that these guidelines should be developed to facilitate the exchange of information in both settings.

FDA 40

FDA Production Regulations Vaccine 40

The Pharma Data

AUGUST 19, 2021

Under Mr. Gorsky’s leadership, the Company has delivered exceptional financial performance, with its market capitalization growing from nearly $180 billion to more than $470 billion as the share price increased over 170%. “I

Pharmaceuticals 52

Pharmaceuticals Vaccine International Government 52

Agency IQ

JUNE 2, 2023

Brevity is the point, according to FDA, which cited research showing that patients “prefer a simplified one-page format for written patient information and are more likely to read information that is short and concise.” It’s worth noting that FDA’s definition of approval includes efficacy supplements, and not just the date of first approval.

FDA 40

FDA FDA Approval Production Regulations 40

The Pharma Data

APRIL 25, 2021

Respiratory syncytial virus is the leading cause of hospitalizations in all infants ,” said Jean-François Toussaint, Global Head of Research and Development, Sanofi Pasteur. “ Research was conducted by AstraZeneca in 21 countries. 2003; vol 143:S127-S132. 5kg) intramuscular injection of nirsevimab or placebo. About Sanofi. .

Virus 40

Virus Trials Disease Hospitals 40

The Pharma Data

JULY 22, 2021

Over more than a decade, we at Biogen engaged in rigorous and science-driven research and development that assessed whether ADUHELM could help patients worldwide who suffer from Alzheimer’s disease. We believe that this will be further established as we collect more data from the ongoing EMBARK study and the post-marketing confirmatory trial.

Disease 52

Disease Research Clinical Trials FDA 52

Drug Target Review

NOVEMBER 30, 2023

After earning a PhD in toxicology from the University of Würzburg in Germany, I started my professional career as a cancer research scientist in the Human Carcinogenesis branch of the National Cancer Institute (USA). Then I was approached to co-found AC Immune in 2003. The field I work in, neurodegeneration, affects so many people.

Disease 95

Disease Therapies Treatment Laboratories 95

Agency IQ

DECEMBER 1, 2023

2060-AV59 Market-Based Approaches Under the National Pollutant Discharge Elimination System (NPDES) Program (Proposed Rule Stage) EPA supports market-based mechanisms to accomplish its mission to protect human health and the environment especially regarding nutrient management. Regan, Case No: 1:16-cv-00364-CRC (D.D.C. 2020) (LEAN).

Regulations 40

Regulations Production Science Compliance 40

FDA Law Blog: Biosimilars

FEBRUARY 11, 2024

Not surprisingly, then-presidential candidate Asa Hutchinson, DEA Administrator from 2001 to 2003, did not sign the letter. The illicit marijuana market remains strong despite state laws legalizing marijuana. Rescheduling increases the ability to research cannabis to determine the physical and mental impacts of cannabis use.

Regulations 59

Regulations Production FDA Approval Drugs 59

The Pharma Data

MAY 5, 2021

The EU marketing authorisation follows the recent approval for the similar expanded LN indication in the U.S. Our world-leading scientists are focusing research on the biology of the immune system with the aim to develop immunological-based medicines that have the potential to alter the course of inflammatory disease.

Therapies 52

Therapies Disease Treatment International 52